Reaktionsgleichung
CCCP(=O)=O.[Cl:7][C:8]1[C:13]([O:14][CH3:15])=[CH:12][C:11]([O:16][CH3:17])=[C:10]([Cl:18])[C:9]=1[C:19]1[C:28]2[N:27]=[CH:26][CH:25]=[N:24][C:23]=2[C:22]([C:29]([OH:31])=O)=[CH:21][CH:20]=1.[CH2:32]([N:34]1[CH2:39][CH2:38][N:37]([C:40]2[CH:46]=[CH:45][C:43]([NH2:44])=[CH:42][CH:41]=2)[CH2:36][CH2:35]1)[CH3:33].CCN(CC)CC>CN(C1C=CN=CC=1)C.CN(C=O)C.CCOC(C)=O.O>[CH2:32]([N:34]1[CH2:35][CH2:36][N:37]([C:40]2[CH:46]=[CH:45][C:43]([NH:44][C:29]([C:22]3[C:23]4[N:24]=[CH:25][CH:26]=[N:27][C:28]=4[C:19]([C:9]4[C:8]([Cl:7])=[C:13]([O:14][CH3:15])[CH:12]=[C:11]([O:16][CH3:17])[C:10]=4[Cl:18])=[CH:20][CH:21]=3)=[O:31])=[CH:42][CH:41]=2)[CH2:38][CH2:39]1)[CH3:33]Komponenten
9
Edukt 4
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 4
Versuchsvorschrift
A mixture of propylphosphonic anhydride (50% in DMF, 0.31 mL, 0.53 mmol, 2 equiv), 8-(2,6-dichloro-3,5-dimethoxy-phenyl)-quinoxaline-5-carboxylic acid (100 mg, 0.26 mmol) (Step 1.1), 4-(4-ethylpiperazin-1-yl)-aniline (Step 1.9) (65 mg, 0.32 mmol, 1.2 equiv), DMAP (2 mg), and Et3N (0.37 mL, 2.65 mmol, 10 equiv) in DMF (2.0 mL), was stirred for 18 h at rt, under an argon atmosphere. The reaction mixture was diluted with EtOAc and H2O. The aqueous layer was separated and extracted with EtOAc. The combined organic phase was washed with brine, dried (Na2SO4), filtered and concentrated. The residue was purified by trituration in Et2O to afford the title compound as a yellow solid: ES-MS: 565.9 [M+H]+; tR=4.26 min (System 1).
Aufarbeitung
- customThe aqueous layer was separated
- extractionextracted with EtOAc
- washThe combined organic phase was washed with brine
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated
- customThe residue was purified by trituration in Et2O
Quellen und Nachweise
- ORD-Eintrag
- ord-28d5a761e9ea4cb595861a2c4423f7ec
- Quelldatensatz
- uspto-grants-2013_09
- Patentnummer
- US08536175B2
Verknüpfte Notizen
Wird geladen…